MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 93 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $291 | -70.9% | 737 | +5.1% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 701 | -40.5% | 0.00% | – |
| Q2 2022 | $1,000 | -85.7% | 1,179 | -50.2% | 0.00% | – |
| Q1 2022 | $7,000 | -83.3% | 2,366 | -74.8% | 0.00% | – |
| Q4 2021 | $42,000 | -10.6% | 9,395 | +46.4% | 0.00% | – |
| Q3 2021 | $47,000 | -2.1% | 6,418 | +29.6% | 0.00% | – |
| Q2 2021 | $48,000 | +14.3% | 4,952 | +40.1% | 0.00% | – |
| Q1 2021 | $42,000 | -19.2% | 3,535 | -46.6% | 0.00% | – |
| Q4 2020 | $52,000 | +52.9% | 6,619 | +30.5% | 0.00% | – |
| Q3 2020 | $34,000 | -2.9% | 5,072 | +8.0% | 0.00% | – |
| Q2 2020 | $35,000 | -39.7% | 4,696 | -49.0% | 0.00% | – |
| Q1 2020 | $58,000 | -44.2% | 9,209 | +33.9% | 0.00% | – |
| Q4 2019 | $104,000 | +420.0% | 6,876 | +248.7% | 0.00% | – |
| Q3 2019 | $20,000 | -78.7% | 1,972 | -68.9% | 0.00% | – |
| Q2 2019 | $94,000 | +32.4% | 6,350 | +46.8% | 0.00% | – |
| Q1 2019 | $71,000 | +3450.0% | 4,325 | +889.7% | 0.00% | – |
| Q4 2018 | $2,000 | -85.7% | 437 | -61.3% | 0.00% | – |
| Q3 2018 | $14,000 | – | 1,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 8,008,204 | $50,292,000 | 45.98% |
| Casdin Capital, LLC | 2,971,034 | $18,658,000 | 1.98% |
| Alphabet Inc. | 3,339,138 | $20,970,000 | 1.38% |
| Opaleye Management Inc. | 434,712 | $2,730,000 | 0.72% |
| Bleichroeder LP | 251,875 | $1,582,000 | 0.41% |
| Eventide Asset Management | 1,789,646 | $11,239,000 | 0.36% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,089,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 4,059,789 | $25,495,000 | 0.31% |
| Leap Investments LP | 12,600 | $79,000 | 0.12% |
| Aries Wealth Management | 12,000 | $77,000 | 0.06% |